Intra-laboratory validated “TigraTest® SARS-CoV-2” — test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens

Intra-laboratory validated “TigraTest® SARS-CoV-2” — test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV (2019-Novel Coronavirus) is a strain of coronavirus from the genus Betacoronavirus, discovered in China at the end of 2019 in patients with pneumonia. Coronavirus infection COVID-19 (COrona VIrus Disease 2019) caus...

Full description

Bibliographic Details
Main Authors: Ivan V. Lyagoskin, Pauline E. Kargopolova, Dmitry A. Obyedkov, Irina Yu. Egorova, Rahim R. Shukurov
Format: Article
Language:Russian
Published: Sankt-Peterburg : NIIÈM imeni Pastera 2022-11-01
Series:Инфекция и иммунитет
Subjects:
validation
tigratest® sars-cov-2
covid-19
t-cell immunity
elispot
diagnostic sensitivity
specificity
variability
Online Access:https://iimmun.ru/iimm/article/viewFile/1855/1504

Internet

https://iimmun.ru/iimm/article/viewFile/1855/1504

Similar Items